Structure of mitogen-activated protein kinase kinase 1 in the DFG-out conformation.
DFG motif
MAP kinases
MEK1
X-ray crystallography
human mitogen-activated protein kinase kinase 1
Journal
Acta crystallographica. Section F, Structural biology communications
ISSN: 2053-230X
Titre abrégé: Acta Crystallogr F Struct Biol Commun
Pays: United States
ID NLM: 101620319
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
received:
03
09
2021
accepted:
04
11
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
5
4
2022
Statut:
ppublish
Résumé
Eukaryotic protein kinases contain an Asp-Phe-Gly (DFG) motif, the conformation of which is involved in controlling the catalytic activity, at the N-terminus of the activation segment. The motif can be switched between active-state (DFG-in) and inactive-state (DFG-out) conformations: however, the mechanism of conformational change is poorly understood, partly because there are few reports of the DFG-out conformation. Here, a novel crystal structure of nonphosphorylated human mitogen-activated protein kinase kinase 1 (MEK1; amino acids 38-381) complexed with ATP-γS is reported in which MEK1 adopts the DFG-out conformation. The crystal structure revealed that the structural elements (the αC helix and HRD motif) surrounding the active site are involved in the formation/stabilization of the DFG-out conformation. The ATP-γS molecule was bound to the canonical ATP-binding site in a different binding mode that has never been found in previously determined crystal structures of MEK1. This novel ATP-γS binding mode provides a starting point for the design of high-affinity inhibitors of nonphosphorylated inactive MEK1 that adopts the DFG-out conformation.
Identifiants
pubmed: 34866601
pii: S2053230X21011687
doi: 10.1107/S2053230X21011687
pmc: PMC8647213
doi:
Substances chimiques
Protein Kinase Inhibitors
0
Protein Kinases
EC 2.7.-
MAP Kinase Kinase 1
EC 2.7.12.2
MAP2K1 protein, human
EC 2.7.12.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
459-464Subventions
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 26440035
Organisme : Japan Agency for Medical Research and Development
ID : JP21am0101111
Références
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Annu Rev Biochem. 2012;81:587-613
pubmed: 22482904
Annu Rev Biochem. 2011;80:769-95
pubmed: 21548788
Biochem Biophys Res Commun. 2012 Jan 6;417(1):5-10
pubmed: 22177953
Cell. 2003 Mar 21;112(6):859-71
pubmed: 12654251
Biochem J. 2000 Oct 15;351 Pt 2:289-305
pubmed: 11023813
Trends Biochem Sci. 2011 Feb;36(2):65-77
pubmed: 20971646
Cell. 1996 Apr 19;85(2):149-58
pubmed: 8612268
J Phys Chem A. 2009 Nov 19;113(46):12763-73
pubmed: 19831376
J Med Chem. 2010 Apr 8;53(7):2681-94
pubmed: 20000735
Nat Struct Mol Biol. 2004 Dec;11(12):1192-7
pubmed: 15543157
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17783-8
pubmed: 17095602
Eur J Med Chem. 2021 Jun 5;218:113386
pubmed: 33774345
ACS Med Chem Lett. 2012 Apr 09;3(5):416-21
pubmed: 24900486
Biochemistry. 2009 Mar 31;48(12):2661-74
pubmed: 19161339
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
pubmed: 17126425
Nat Rev Cancer. 2015 Oct;15(10):577-92
pubmed: 26399658
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
J Biol Chem. 1993 May 25;268(15):11435-9
pubmed: 8388392
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Chem Rev. 2001 Aug;101(8):2271-90
pubmed: 11749373
Biochemistry. 2007 Feb 6;46(5):1358-67
pubmed: 17260965
FASEB J. 1995 Jun;9(9):726-35
pubmed: 7601337